re: News: MEC Resources: Update on PEP11 and ... I thought the entire interview was fairly good for holders. DB really did say a fair bit without letting everything out of the bag. I just wished that they would regularly inform investors via ASX announcements as to just what is going on.
He said more about Seaclam in the interview than what has been announced to investors. The results of Seaclam should provide interesting reading once they are eventually released to us. The 40 metre section will be one aspect to look at as will the upward dip that the drill bit missed.
Then you have the other interests of MMR which DB also discussed.
All in all I can also see some future with MMR after Seaclam in PEP11. We have some way to go yet and I for one am still holding.
DB still has a way to go to convince me yet as to the real possibities of this company but he did handle the interview very well and with great confidence.
- Forums
- ASX - By Stock
- MMR
- News: MEC Resources: Update on PEP11 and Half Yea
MMR
mec resources limited
Add to My Watchlist
0.00%
!
0.4¢

News: MEC Resources: Update on PEP11 and Half Yea, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.399M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 5166279 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 4175000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 5166279 | 0.004 |
12 | 9718125 | 0.003 |
7 | 9850000 | 0.002 |
12 | 33105000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 4175000 | 4 |
0.006 | 12474101 | 7 |
0.007 | 8089274 | 3 |
0.008 | 4000000 | 1 |
0.009 | 700000 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
MMR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online